|Bid||3.5600 x N/A|
|Ask||3.6300 x N/A|
|Day's range||3.4700 - 3.6500|
|52-week range||3.1500 - 11.2800|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
At the moment, Tilray Brands (NASDAQ: TLRY) isn't a stock that's an obvious buy, as the cannabis industry is getting punished by the bear market and price compression with no relief in sight. The stock is far too risky for most investors to buy today due to the range of headwinds it faces. As a company that aspires to be the largest marijuana business in the world, Tilray's cultivation, manufacturing, distribution, and retail operations are scattered around the globe, with the largest concentration of its resources located in North America and the European Union.
On that note, here are a couple of severely beaten-down growth stocks that are popular among investors, but only one of them has a credible path to stay in business. With ambitions to become the world's biggest seller of legal cannabis products, Tilray Brands (NASDAQ: TLRY) is also a growth stock that's remarkably inexpensive. Despite reporting $144 million in revenue for its fiscal second quarter and free cash flow (FCF) of $25.4 million, its shares are down 42.7% in the last three years because of persistent unprofitability and wild oversupply compared to demand across several continents.
Tilray's global growth means that the Canadian cannabis company is unlikely to stay down for the count.